Member Info for Retireby40

From waterloo01 on advfn -

https://www.medrxiv.org/content/10.1101/2021.06.18.21259162v1

This validated the use of wastewater for early detection and although their system is better than manual sampling it still isn’t in real-time and as the AI learns we can also forecast the spread etc.

I don’t wanna Labour the point but leaving it to the very last minute doesn’t look as professional and Many would like.

Anyway, let’s see what the annual report brings. Hoping we have some decent post YE commentary in the RNS. Haven’t heard a lot from our core labskin business, what’s going on with Parity etc. Looking forward to the detail.

A great result snd hopefully next round we go to a 4 at the back and get Grealish or Foden in the starting 11. Need more creativity.

I just think publishing the AR at the latest moment and using a footy match at 5pm as an excuse wouldn’t sit well with fund managers who will think it’s amateurish. Anyway, a minor point and hopefully the co is able to report to the market in a more timely manner.

The thing is most PLCs have to have their AGM within 6 months of YE and the AR sent out just shy of a month before (so one can digest ahead of the AGM) and we have always got the AR out end of June. I realise it’s tricky with Covid and MWG acquisition but I hope next year we sort our **** out as it’s Micky Mouse. Unless there is some news as Bella suggested (I doubt it) it’s poor to literally get it out last minute, intraday on the last day FFS.

Anyway, let’s see what the RNS brings.

I assume if you buy 10,000 boxes so 250,000 tests the cost will come down, I suspect maybe even £5.50/test.

Yeah my fault going over old/redundant ground. Apologies all.

Took a while! Here’s to a a massive H2! Cheers

Head in hands embarrassed! Thanks, Chesh. I’ve lost the plot as remember seeing that. Agreed the £10m will be revised northwards and no need for a profit warning when that was published. Deary me!

Last year’s figures aren’t too important but H2 could and should be transformational. China deal tied up soon and operational Sept and EU legislation comes in re monitoring wastewater in Oct. We have the best solution and only co to have it.

I believe most of the labskin revenue is recurring (framework agreements) so they have a lot of visibility on that. I would be surprised if they can’t see more than £10m in revenue given £3.6m MWG already secured, skintrustclub seems to have kicked off well and £2.4m mainly labskin work Q4. Anyway, time will tell! Hoping we have a decent post YE update as we haven’t heard much from the core business - labskin. Hopefully that has already produced £5m+ H1 on its own.

Only £6m forecast for this year but the note was before MWG acquisition. Still it had £250k profit.

https://www.deepverge.com/wp-content/uploads/2020/01/Integumen_INITIATION_FINAL.pdf

As I said I’m not worried if we had a chunky loss last year but i do hope we get a revised forecast with it.

I may be wrong as we perhaps should have had a profit warning but I’m not sure if that had to be done. Agreed it’s about looking ahead but given we did £2.4m in Q4 without MWG I find £10m poor especially as we already have £3.6m MWG orders. Anyway, if we did lose a fair bit last year I hope we get a revised forecast for this year. Even without the JV I expect £15m. If we did 4 Qs of £2.4m is £9.6m snd add £3.6m for MWG is £13.2m so we only need £1.8m for more labskin work, skintrustclub and MWG orders to get to it.

GB said momentum continued into this year from last so he implied we would do more than £2.4m Q1. Annoying we’ll have to wait until end of Sept for interim’s.

We now have 8 MMs so have a new one. Either STFL or JBER me thinks.

Although the £10m needed for growth and I imagine the Chinese wanted us to have a stronger balance sheet I suspect we will show a hefty loss last year. TP note suggested a modest profit but I imagine it will be a loss of £2m or so (absolute guess!). That said we didn’t have a profit warning so I may be out of line (especially as Q4 was EBITDA positive). Anyway, we shall see but I’m not concerned but hope we get a revised forecast of £15n or so given we did £2.4m in Q4 (without MWG) so with £3.6m in MWG orders this year we should be nearer to £20m than £10m. On no growth from 2020 we would be £9.6m then we have £3.6m confirmed MWG and skintrustclub. An interesting few days ahead.

Super post and couldn’t agree more. I’ve been adding (increasing my average) since my first buy last spring. Huge potential and another US tier 1 partner to sign up soon. I imagine the Pepsi co brand managers are helping us in terms of getting us on more radars. Exciting times.

Fair play to them. Better terms which is why it took longer. Onwards and upwards.

I doubt they are profitable and AR due before June 30. This is a high growth small cap (treble digit growth each year) and with £10m on balance sheet it’s about growing at this stage not profit. Sure 2020 will show a hefty loss but I’m looking forward and believe the wastewater potential transformational. I’m sure our Chinese partners would have wanted a stronger balance sheet but also we need cash to fund growth. Best to raise money and dominate the space rather than go very slowly and risk others coming in.

We are the first so dominate the space snd reap the rewards.

China deal hasn't changed. The RNS said it was expected by June 30th. Timeline slipping into Q3 is also to ensure confirmation of live data alerts in multiple sites, in multiple continents for obvious value reasons in negotiations.

https://twitter.com/gjbrandon/status/1407971017356611589?s=21

Dominate the space, get units all over the world and the recurring revenues will ensure we are a monster. Reagents and recurring AI revs. Great business model.

Microtox(R) PD claims world first live data alerts of SARS-Cov-2 in wastewater treatment plants

All opinions are personal. Good old tautology.

Annual report due and details on Chinese deal before end of the month. Sure there’ll be more volume next week too. A big end to the month and H1.